IRIS
CELLERINO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.712
NA - Nord America 1.284
AS - Asia 1.046
Continente sconosciuto - Info sul continente non disponibili 202
SA - Sud America 96
AF - Africa 23
OC - Oceania 3
Totale 7.366
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 4.544
US - Stati Uniti d'America 1.197
SG - Singapore 358
CN - Cina 264
VN - Vietnam 158
BD - Bangladesh 153
BR - Brasile 59
CA - Canada 38
FR - Francia 36
HK - Hong Kong 30
GB - Regno Unito 28
DE - Germania 21
FI - Finlandia 18
NL - Olanda 17
AR - Argentina 14
IN - India 14
MX - Messico 13
IQ - Iraq 11
JP - Giappone 10
VE - Venezuela 10
JM - Giamaica 9
PH - Filippine 9
PK - Pakistan 9
EC - Ecuador 7
RU - Federazione Russa 7
MA - Marocco 6
PL - Polonia 6
TR - Turchia 6
CR - Costa Rica 5
ES - Italia 5
TN - Tunisia 5
UA - Ucraina 5
ZA - Sudafrica 5
CO - Colombia 4
ID - Indonesia 4
TT - Trinidad e Tobago 4
CH - Svizzera 3
EE - Estonia 3
GT - Guatemala 3
HT - Haiti 3
JO - Giordania 3
NI - Nicaragua 3
PR - Porto Rico 3
RO - Romania 3
SV - El Salvador 3
AU - Australia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CW - ???statistics.table.value.countryCode.CW??? 2
GR - Grecia 2
IE - Irlanda 2
KE - Kenya 2
LT - Lituania 2
MY - Malesia 2
RS - Serbia 2
SA - Arabia Saudita 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BE - Belgio 1
BH - Bahrain 1
BW - Botswana 1
CG - Congo 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
HN - Honduras 1
IR - Iran 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
MD - Moldavia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 7.166
Salva come PNG Salva come JPEG
Città #
Genoa 2.360
Genova 911
Vado Ligure 615
Rapallo 389
San Jose 235
Ashburn 203
Singapore 185
Beijing 66
Ho Chi Minh City 61
New York 52
Milan 45
Rome 33
Council Bluffs 30
Hong Kong 30
Lauterbourg 29
Santa Clara 26
Hanoi 25
Los Angeles 23
Dallas 19
Turin 19
Boardman 17
Helsinki 17
Frankfurt am Main 16
Chicago 14
Buffalo 12
Phoenix 12
Bordighera 11
Brasília 11
Naples 11
Philadelphia 11
St Louis 11
Da Nang 10
Montreal 10
Haiphong 9
Mexico City 8
Tokyo 8
Houston 7
Orem 7
Toronto 7
Atlanta 6
Gainesville 6
London 6
McCaskill 5
Miami 5
Washington 5
Albuquerque 4
Aurora 4
Biên Hòa 4
Bologna 4
Boston 4
Caracas 4
Cardiff 4
Catania 4
Charlotte 4
Cincinnati 4
Kingston 4
Louisville 4
Ninh Bình 4
Paris 4
Porto Alegre 4
San Francisco 4
San José 4
São Paulo 4
Tampa 4
Trento 4
Valenza 4
Virginia Beach 4
Amman 3
Arlington 3
Baghdad 3
Brooklyn 3
Camberwell 3
Can Tho 3
Casablanca 3
Cleveland 3
Curitiba 3
Detroit 3
Florence 3
Guatemala City 3
Guayaquil 3
Hollywood 3
Hải Dương 3
Johannesburg 3
Karbala 3
Managua 3
Nuremberg 3
Queens 3
Quảng Ngãi 3
Rotterdam 3
San Salvador 3
Shenzhen 3
Thái Bình 3
Winchester 3
Acalanes Ridge 2
Amsterdam 2
Athens 2
Baku 2
Baltimore 2
Belgrade 2
Bensalem 2
Totale 5.778
Salva come PNG Salva come JPEG
Nome #
Different MRI patterns in MS worsening after stopping fingolimod 212
Osteopathic Manipulative Therapy and Multiple Sclerosis: A Proof-of-Concept Study 211
A novel prion protein gene-truncating mutation causing autonomic neuropathy and diarrhea 190
Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS 190
Levodopa-induced neutropenia. 182
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 174
Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions? 171
Corneal epithelial dendritic cells in patients with multiple sclerosis: An in vivo confocal microscopy study 170
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population 158
Embracing resilience in multiple sclerosis: a new perspective from COVID-19 pandemic 156
Risk of Persistent Disability in Patients with Pediatric-Onset Multiple Sclerosis 152
Homonymous hemianopia as the first sign of posterior cortical atrophy 147
COVID-19 pandemic and mental distress in Multiple Sclerosis: implications for clinical management 143
Assessing upper limb function in Multiple Sclerosis by an engineered glove 136
Cognitive changes in patients with relapse-free MS treated with high efficacy therapies: the predictive value of paramagnetic rim lesions 135
Pediatric optic neuritis and anti MOG antibodies: a cohort of Italian patients 135
Impact of treatment on cellular immunophenotype in MS: A cross-sectional study 135
The early effect of cladribrine versus fingolimod on clinical and MRI measures in relapsing remitting multiple sclerosis 133
Central vein sign and diffusion MRI differentiate microstructural features within white matter lesions of multiple sclerosis patients with comorbidities 131
On the Assessment of Gray Code Kernels for Motion Characterization in People with Multiple Sclerosis: A Preliminary Study 130
Multiscale networks in multiple sclerosis 123
CD19+ B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis 122
Clinical and radiological correlates of apathy in multiple sclerosis 122
Neuroaxonal Degeneration in Patients With Multiple Sclerosis: An Optical Coherence Tomography and in Vivo Corneal Confocal Microscopy Study 122
EXPLORING THE INTERACTION BETWEEN FOCAL INFLAMMATION AND AXONAL INJURY IN MULTIPLE SCELROSIS: A NEW MECHANISM-DRIVEN FRAMEWORK TO MONITOR DISEASE ACTIVITY AND PROGRESSION 119
Corneal sub-basal nerve plexus analysis in patients with multiple sclerosis 119
In-vivo characterization of macro- and microstructural injury of the subventricular zone in relapsing-remitting and progressive multiple sclerosis 118
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis 118
Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study 113
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study 112
Safety of anti-varicella zoster virus vaccination in patients with multiple sclerosis treated with natalizumab: A case series 111
Tailoring B cell depletion therapy in MS according to memory B cell monitoring 105
Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography Study 104
The effect of Cladribine and Fingolimod treatments on retinal atrophy 103
Effect of ocrelizumab treatment on retinal atrophy: preliminary results from a single-center observational study 103
Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis 103
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic? 101
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 100
Evaluating the central vein sign in paediatric-onset multiple sclerosis: A case series study 99
What happens after fingolimod discontinuation? A multicentre real-life experience 97
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 94
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial 93
Brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein disease 90
Lesion phenotyping based on magnetic susceptibility in pediatric multiple sclerosis 85
Predicting disease severity in Multiple Sclerosis using multimodal data and machine learning 82
Erratum: Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography Study 81
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study 81
The role of disconnection in explaining disability in multiple sclerosis 81
Severe disease activity in MS patients treated with cladribine after fingolimod withdrawal 80
Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors 74
Environmental risk factors for multiple sclerosis: a comprehensive systematic review and meta-analysis 67
Physical exercise moderates the effects of disability on depression in people with multiple sclerosis during the covid-19 outbreak 66
Vaccinations in patients with multiple sclerosis: a real-world, single-center experience 65
Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: A longitudinal multicenter study 63
Assessing Optic Nerve Involvement in Multiple SclerosisUsing Optical Coherence Tomography and Magnetic Resonance Imaging 62
Vaccinations in patients with multiple sclerosis: a real-world, single-center, experience 60
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy 60
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 58
Relationship between ovarian reserve and disease activity in women with multiple sclerosis 58
Positioning siponimod and the post-treatment gap: the unmet needs of SPMS patients in Italian real-world practice 53
ELEVATED RISK OF THROMBOTIC MANIFESTATIONS OF SARS-COV-2 INFECTION IN CANCER PATIENTS: A LITERATURE REVIEW 52
The “central vein sign” to differentiate multiple sclerosis frommigraine 47
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study 43
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 43
Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness z Scores 43
Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis 43
Childhood and Adolescent Environmental Risk Factors for Multiple Sclerosis: A Systematic Review With Meta-Analysis 41
Safety assessment of switching from fingolimod to siponimod: An Italian multicenter prospective study 40
First demyelinating attack in children: A twelve year single center cohort 38
Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis 30
Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing-Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study 29
Functional and effective connectivity disruptions of the dopaminergic reward circuit in multiple sclerosis patients with depression 20
null 20
Task-oriented virtual reality and brain functional plasticity in progressive multiple sclerosis: A randomized controlled trial on upper limb rehabilitation 19
Totale 7.366
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.628
article - articoli 26.376
book - libri 0
conference - conferenze 554
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 354
Totale 54.912
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022240 0 0 5 21 13 19 4 55 24 41 9 49
2022/2023469 34 44 11 51 52 62 4 33 77 4 77 20
2023/2024556 20 42 16 58 34 66 156 24 24 26 30 60
2024/20251.597 87 105 64 102 208 163 163 264 97 73 139 132
2025/20263.077 335 134 180 237 356 164 362 182 264 288 226 349
2026/2027687 282 171 234 0 0 0 0 0 0 0 0 0
Totale 7.366